BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21161944)

  • 1. A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types.
    Mettu RK; Wan YW; Habermann JK; Ried T; Guo NL
    Int J Biol Markers; 2010; 25(4):219-28. PubMed ID: 21161944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.
    Guo NL; Wan YW
    Artif Intell Med; 2012 Jun; 55(2):97-105. PubMed ID: 22326768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types.
    Wan YW; Qian Y; Rathnagiriswaran S; Castranova V; Guo NL
    Oncol Rep; 2010 Aug; 24(2):489-94. PubMed ID: 20596637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome.
    Habermann JK; Doering J; Hautaniemi S; Roblick UJ; Bündgen NK; Nicorici D; Kronenwett U; Rathnagiriswaran S; Mettu RK; Ma Y; Krüger S; Bruch HP; Auer G; Guo NL; Ried T
    Int J Cancer; 2009 Apr; 124(7):1552-64. PubMed ID: 19101988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction.
    Wan YW; Sabbagh E; Raese R; Qian Y; Luo D; Denvir J; Vallyathan V; Castranova V; Guo NL
    PLoS One; 2010 Aug; 5(8):e12222. PubMed ID: 20808922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of gene expression-based prediction of survival in non-small cell lung cancer.
    Guo NL; Wan YW; Tosun K; Lin H; Msiska Z; Flynn DC; Remick SC; Vallyathan V; Dowlati A; Shi X; Castranova V; Beer DG; Qian Y
    Clin Cancer Res; 2008 Dec; 14(24):8213-20. PubMed ID: 19088038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis.
    Bonnet F; Guedj M; Jones N; Sfar S; Brouste V; Elarouci N; Banneau G; Orsetti B; Primois C; de Lara CT; Debled M; de Mascarel I; Theillet C; Sévenet N; de Reynies A; MacGrogan G; Longy M
    BMC Med Genomics; 2012 Nov; 5():54. PubMed ID: 23186559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities.
    Garman KS; Acharya CR; Edelman E; Grade M; Gaedcke J; Sud S; Barry W; Diehl AM; Provenzale D; Ginsburg GS; Ghadimi BM; Ried T; Nevins JR; Mukherjee S; Hsu D; Potti A
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19432-7. PubMed ID: 19050079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression signature predicts recurrence in lung adenocarcinoma.
    Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
    Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal responses among common carcinomas correlated with clinicopathologic features.
    Chen JL; Espinosa I; Lin AY; Liao OY; van de Rijn M; West RB
    Clin Cancer Res; 2013 Sep; 19(18):5127-35. PubMed ID: 23804424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer.
    Lee J; Li B; Cui Y; Sun X; Wu J; Zhu H; Yu J; Gensheimer MF; Loo BW; Diehn M; Li R
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1098-1106. PubMed ID: 29439884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model.
    Mitra R; Lee J; Jo J; Milani M; McClintick JN; Edenberg HJ; Kesler KA; Rieger KM; Badve S; Cummings OW; Mohiuddin A; Thomas DG; Luo X; Juliar BE; Li L; Mesaros C; Blair IA; Srirangam A; Kratzke RA; McDonald CJ; Kim J; Potter DA
    Clin Cancer Res; 2011 May; 17(9):2934-46. PubMed ID: 21242119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer.
    Coulouarn C; Factor VM; Thorgeirsson SS
    Hepatology; 2008 Jun; 47(6):2059-67. PubMed ID: 18506891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA signature predicts survival and relapse in lung cancer.
    Yu SL; Chen HY; Chang GC; Chen CY; Chen HW; Singh S; Cheng CL; Yu CJ; Lee YC; Chen HS; Su TJ; Chiang CC; Li HN; Hong QS; Su HY; Chen CC; Chen WJ; Liu CC; Chan WK; Chen WJ; Li KC; Chen JJ; Yang PC
    Cancer Cell; 2008 Jan; 13(1):48-57. PubMed ID: 18167339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
    Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M
    J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene expression signature of genetic instability in colon cancer.
    Giacomini CP; Leung SY; Chen X; Yuen ST; Kim YH; Bair E; Pollack JR
    Cancer Res; 2005 Oct; 65(20):9200-5. PubMed ID: 16230380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
    Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
    J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.